Invention Grant
- Patent Title: Use of A2A adenosine receptor agonists
- Patent Title (中): 使用A2A腺苷受体激动剂
-
Application No.: US11253322Application Date: 2005-10-19
-
Publication No.: US07655636B2Publication Date: 2010-02-02
- Inventor: Toufigh Gordi , Ann Walls Olmsted , Hsiao Dee Lieu , Luiz Belardinelli
- Applicant: Toufigh Gordi , Ann Walls Olmsted , Hsiao Dee Lieu , Luiz Belardinelli
- Applicant Address: US CA Foster City
- Assignee: Gilead Palo Alto, Inc.
- Current Assignee: Gilead Palo Alto, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Swiss Tanner, P.C.
- Main IPC: A61K31/70
- IPC: A61K31/70
Abstract:
The present invention relates to methods for producing coronary vasodilation with little peripheral vasodilation by administering doses of a pharmaceutical composition including regadenoson, named (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide, — an adenosine A2A receptor agonist — to a human in an amount sufficient to increase the average coronary peak flow velocity by at least about 16.5 cm/sec.
Public/Granted literature
- US20060084625A1 Use of A2A adenosine receptor agonists Public/Granted day:2006-04-20
Information query
